FDA clears Medtronic’s LINQ II ICM for use in paediatric patients
MedTech company, Medtronic’s LINQ II Insertable Cardiac Monitor (ICM) system has received 510(k) clearance by the US FDA for use in paediatric patients over the age of 2 who have heart rhythm abnormalities and require long-term, continuous monitoring. It is the first-and-only ICM to receive this clearance.